Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · IEX Real-Time Price · USD
2.610
-0.090 (-3.33%)
At close: Jul 19, 2024, 4:00 PM
2.600
-0.010 (-0.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $326.94 million as of July 22, 2024. Its market cap has decreased by -24.88% in one year.
Market Cap
326.94M
Enterprise Value
179.20M
1-Year Change
-24.88%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since August 7, 2020, Nautilus Biotechnology's market cap has increased from $167.80M to $326.94M, an increase of 94.84%. That is a compound annual growth rate of 18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 326.90M | -12.50% |
| Dec 29, 2023 | 373.60M | 66.41% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.20M | 208.93% |
| Dec 31, 2020 | 208.20M | 24.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ModivCare | 335.24M |
| Nevro | 334.23M |
| Kamada | 332.20M |
| ADC Therapeutics | 331.02M |
| Inozyme Pharma | 329.69M |
| XOMA Corporation | 326.58M |
| Foghorn Therapeutics | 326.44M |
| Spok Holdings | 325.55M |